90 results
S-3ASR
EX-4.3
SANA
Sana Biotechnology Inc
1 Mar 24
Automatic shelf registration
4:08pm
Series in respect of any matters, provided that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture … , lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally
S-3ASR
EX-5.1
SANA
Sana Biotechnology Inc
1 Mar 24
Automatic shelf registration
4:08pm
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, and entitled to the benefits
8-K
EX-1.1
SANA
Sana Biotechnology Inc
8 Feb 24
Sana Biotechnology Announces Pricing of Upsized Public Offering
5:20pm
as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand from the offering … to reflect not only the relative benefits referred to in clause 8(d)(i) above but also the relative fault of the Company on the one hand
424B5
SANA
Sana Biotechnology Inc
8 Feb 24
Prospectus supplement for primary offering
4:49pm
designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased
424B5
uakkil w52
7 Feb 24
Prospectus supplement for primary offering
5:05pm
8-K
EX-99.1
kqtlbyq7mzjh4wl
9 Jan 24
Regulation FD Disclosure
9:00am
8-K
EX-99.1
px2sg4pt 1vi4
8 Nov 23
Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
4:14pm
8-K
iuvyr54jdy
10 Oct 23
Cost Associated with Exit or Disposal Activities
4:21pm
8-K
EX-99.1
sry5fofk2h6w h7gdq
10 Oct 23
Cost Associated with Exit or Disposal Activities
4:21pm
8-K
EX-99.1
9011irqjz c923o6ihlo
3 Aug 23
Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates
4:14pm
8-K
EX-99.1
4y005ivemdvn43rnug4x
8 May 23
Sana Biotechnology Reports First Quarter 2023 Financial Results and Business Updates
4:25pm
8-K
tcfn3r0n0gy
10 Apr 23
Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery and Development to Lead its R&D Organization
4:15pm